Ratings by Jefferies (Roger Song)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/18/2021 Pieris Pharmaceuticals PIRS New Coverage Buy
(N/A)
1.88
(4.46)
137.23% Details
5/18/2021 Equillium EQ New Coverage Buy
(N/A)
5.42
(5.98)
10.33% Details
4/29/2021 Cara Therapeutics CARA Maintain Buy
(N/A)
 
 
  Details
4/13/2021 Finch Therapeutics Group Inc. FNCH New Coverage Buy
(N/A)
17.18
(16.40)
-4.54% Details
4/5/2021 Molecular Templates MTEM Maintain Buy
(N/A)
 
 
  Details
3/23/2021 CytomX Therapeutics CTMX Upgrade Buy
(Hold)
8.52
(6.65)
-21.95% Details
2/8/2021 Atreca Inc. BCEL New Coverage Buy
(N/A)
14.93
(9.00)
-39.72% Details
11/2/2020 Replimune Group REPL New Coverage Buy
(N/A)
43.18
(37.57)
-12.99% Details
9/8/2020 Molecular Templates MTEM New Coverage Buy
(N/A)
10.26
(8.47)
-17.45% Details
9/2/2020 Sutro Biopharma STRO New Coverage Buy
(N/A)
10.01
(19.05)
90.31% Details
1/3/2019 Aevi GNMX Maintain Hold
(N/A)
 
 
  Details
11/2/2018 Amarin Corporation AMRN Maintain Buy
(N/A)
 
 
  Details
10/15/2018 AcelRx Pharmaceuticals ACRX Upgrade Buy
(Hold)
3.98
(1.38)
-65.33% Details